Reid Hoffman co-founded LinkedIn, is a partner at Greylock Partners, serves on Microsoft's board, and was an early investor in Facebook, Airbnb, and OpenAI. He authored 'Blitzscaling' and 'Super Agency'.
no scored calls yet — needs a stated position or a categorical verdict, with a matured window vs SPY
AI-native drug discovery companies can leverage frontier models to analyze therapeutic molecules and molecular attributes at unprecedented depth, representing a major untapped application area beyond coding.
Frontier model companies like OpenAI can only reach their position through deep compute partnerships with hyperscalers like Microsoft, creating a symbiotic relationship where startups provide innovation and incumbents provide infrastructure.
Microsoft's hyperscale cloud infrastructure and partnership with OpenAI position it as the critical compute provider for frontier model training and inference deployment, with GPUs fully allocated across customer inference, internal R&D, and product deployment.